Headshot of Scott Tomlins, MD, PhD

Scott Tomlins, MD, PhD Co-founder & Chief Medical Officer, Strata Oncology

  • March 16, 2023  

    A New Biomarker to Optimize Immunotherapy for People with Cancer

    With: Scott Tomlins, MD, PhD

    Immunotherapy—a type of treatment that harnesses a patient’s own immune system to fight cancer—has been a “game changer” for many patients. It can be difficult, however, to predict whether or not a given person would benefit from immunotherapy, especially when it comes to drugs that target the immune system molecules PD-1 and PD-L1. Our Curious Dr. George asks Scott Tomlins, MD, PhD, Co-founder and… Read more »

  • March 3, 2022  

    More Information from Less Tissue: Strata Oncology Excels

    With: Scott Tomlins, MD, PhDLaura E. Lamb, PhD

    For a growing number of advanced cancer patients, molecular testing of tumor tissue is an essential step in identifying their best options for treatment. Strata Oncology is one company offering this kind of test. Here, our Curious Dr. George asks two of its leaders what sets Strata apart. Curious Dr. George: No loop is stronger than its weakest link. In the “brain-to-brain” concept of… Read more »